Tudor Investment Corp’s Enliven Therapeutics ELVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-13,363
| Closed | -$263K | – | 1763 |
|
|
2025
Q1 | $263K | Buy |
+13,363
| New | +$263K | ﹤0.01% | 1361 |
|
|
2024
Q3 | – | Sell |
-24,221
| Closed | -$566K | – | 1692 |
|
|
2024
Q2 | $566K | Buy |
+24,221
| New | +$566K | ﹤0.01% | 1161 |
|
|
2022
Q4 | – | Sell |
-6,126
| Closed | -$56K | – | 1667 |
|
|
2022
Q3 | $56K | Sell |
6,126
-6,847
| -53% | -$62.6K | ﹤0.01% | 1501 |
|
|
2022
Q2 | $63K | Sell |
12,973
-8
| -0.1% | -$39 | ﹤0.01% | 1473 |
|
|
2022
Q1 | $98K | Hold |
12,981
| – | – | ﹤0.01% | 1434 |
|
|
2021
Q4 | $117K | Hold |
12,981
| – | – | ﹤0.01% | 1510 |
|
|
2021
Q3 | $212K | Buy |
+12,981
| New | +$212K | ﹤0.01% | 1414 |
|